BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

Paused · Phase 3 · Has a placebo group

Conditions studied: Recurrent Clostridium Difficile Infection

In brief

The primary objective of this study is to evaluate the efficacy of BIO-K+ CL1285 for prevention of recurrent Clostridium difficile infection.

Key facts

Study ID
NCT01202630
Run by
Bio-K Plus International Inc.
People needed
140
Starts
2010-06-01
Expected to finish
2016-01-01
Last updated by the study team
2016-01-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.